In vitro T-cell generation from adult, embryonic, and induced pluripotent stem cells: Many roads to one destination

Stem Cells

Volumn 33, Issue 11, 2015, Pages 3174-3180

  Smith, Michelle J ^a   Webber, Beau R ^a   Mohtashami, Mahmood ^b   Stefanski, Heather E ^a   Zúñiga Pflücker, Juan Carlos ^b   Blazar, Bruce R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Sunnybrook Health Sciences Centre   (Canada)

Author keywords

CD34 + ; Cell culture; Cord blood; Differentiation; Embryonic stem cells; Hematopoietic stem cells; Induced pluripotent stem cells; T cells

Indexed keywords

ADULT; ARTICLE; CELL DIFFERENTIATION; EMBRYO; EMBRYONIC STEM CELL; FEEDER CELL; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; NONHUMAN; PLURIPOTENT STEM CELL; T LYMPHOCYTE; ADULT STEM CELL; ANIMAL; INDUCED PLURIPOTENT STEM CELL; PHYSIOLOGY; TRANSPLANTATION;

ADULT; ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; PLURIPOTENT STEM CELLS; T-LYMPHOCYTES;

EID: 84945452123     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2115     Document Type: Article

References (59)

1. Radtke F, Wilson A, Stark G, et al., Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999; 10: 547-558.
2. Pui JC, Allman D, Xu L, et al., Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 1999; 11: 299-308.
3. Nakano T, Kodama H, Honjo T,. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 1994; 265: 1098-1101.
4. Ciofani M, Zúñiga-Pflücker JC,. Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat Immunol 2005; 6: 881-888.
5. Dervovic DD, Ciofani M, Kianizad K, et al., Comparative and functional evaluation of in vitro generated to ex vivo CD8-T cells. J Immunol 2012; 189: 3411-3420.
6. Schmitt TM, Zúñiga-Pflücker JC,. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 2002; 17: 749-756.
7. Ciofani M, Knowles GC, Wiest DL, et al., Stage-specific and differential notch dependency at the alphabeta and gammadelta T lineage bifurcation. Immunity 2006; 25: 105-116.
8. Radtke F, Wilson A, Mancini SJC, et al., Notch regulation of lymphocyte development and function. Nat Immunol 2004; 5: 247-253.
9. Abe N, Hozumi K, Hirano K-I, et al., Notch ligands transduce different magnitudes of signaling critical for determination of T-cell fate. Eur J Immunol 2010; 40: 2608-2617.
10. Hozumi K, Negishi N, Suzuki D, et al., Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo. Nat Immunol 2004; 5: 638-644.
11. Hozumi K, Mailhos C, Negishi N, et al., Delta-like 4 is indispensable in thymic environment specific for T cell development. J Exp Med 2008; 205: 2507-2513.
12. Koch U, Fiorini E, Benedito R, et al., Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. J Exp Med 2008; 205: 2515-2523.
13. Besseyrias V, Fiorini E, Strobl LJ, et al., Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. J Exp Med 2007; 204: 331-343.
14. Mohtashami M, Shah DK, Nakase H, et al., Direct comparison of Dll1- and Dll4-mediated notch activation levels shows differential lymphomyeloid lineage commitment outcomes. J Immunol 2010; 185: 867-876.
15. Awong G, La Motte-Mohs RN, Zúñiga-Pflücker JC,. Generation of pro-T cells in vitro: Potential for immune reconstitution. Semin Immunol 2007; 19: 341-349.
16. De Smedt M, Leclercq G, Vandekerckhove B, et al., T-lymphoid differentiation potential measured in vitro is higher in CD34+CD38-/lo hematopoietic stem cells from umbilical cord blood than from bone marrow and is an intrinsic property of the cells. Haematologica 2011; 96: 646-654.
17. Awong G, Herer E, La Motte-Mohs RN, et al., Human CD8-T cells generated in vitro from hematopoietic stem cells are functionally mature. BMC Immunol 2011; 12: 22.
18. Awong G, Herer E, Surh CD, et al., Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells. Blood 2009; 114: 972-982.
19. Van Coppernolle S, Verstichel G, Timmermans F, et al., Functionally mature CD4 and CD8 TCRalphabeta cells are generated in OP9-DL1 cultures from human CD34-+-hematopoietic cells. J Immunol 2009; 183: 4859-4870.
20. Zakrzewski JL, Suh D, Markley JC, et al., Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nat Biotechnol 2008; 26: 453-461.
21. Awong G, Singh J, Mohtashami M, et al., Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture. Blood 2013; 122: 4210-4219.
22. Zakrzewski JL, Kochman AA, Lu SX, et al., Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat Med 2006; 12: 1039-1047.
23. Freedman AR, Zhu H, Levine JD, et al., Generation of human T lymphocytes from bone marrow CD34-+-cells in vitro. Nat Med 1996; 2: 46-51.
24. Mohtashami M, Zuniga-Pflucker JC,. Cutting edge: Three-dimensional architecture of the thymus is required to maintain delta-like expression necessary for inducing T cell development. J Immunol 2006; 176: 730-734.
25. Mohtashami M, Shah DK, Kianizad K, et al., Induction of T-cell development by Delta-like 4-expressing fibroblasts. Int Immunol 2013; 25: 601-611.
26. Smeets MFMA, Mackenzie-Kludas C, Mohtashami M, et al., Removal of myeloid cytokines from the cellular environment enhances T-cell development in vitro. Int Immunol 2013; 25: 589-599.
27. Dervovic DD, Liang HCY, Cannons JL, et al., Cellular and molecular requirements for the selection of in vitro-generated CD8-T cells reveal a role for notch. J Immunol 2013; 191: 1704-1715.
28. Clark RA, Yamanaka K-I, Bai M, et al., Human skin cells support thymus-independent T cell development. J Clin Invest 2005; 115: 3239-3249.
29. Lapenna A, B-Lynch C, Kapeni C, et al., A simple model system enabling human CD34-+-cells to undertake differentiation towards T cells. PLoS One 2013; 8: e69572.
30. Meek B, Van Elssen CHMJ, Huijskens MJAJ, et al., T cells fail to develop in the human skin-cell explants system; an inconvenient truth. BMC Immunol 2011; 12: 17.
31. Gehre N, Nusser A, Muenchow von L, et al., A stromal cell free culture system generates mouse pro-T cells that can reconstitute T-cell compartments in vivo. Eur J Immunol 2014; 45: 932-942.
32. Menon T, Firth AL, Scripture-Adams DD, et al., Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs. Cell Stem Cell 2015; 16: 367-372.
33. Ikawa T, Hirose S, Masuda K, et al., An essential developmental checkpoint for production of the T cell lineage. Science 2010; 329: 93-96.
34. Janas ML, Varano G, Gudmundsson K, et al., Thymic development beyond beta-selection requires phosphatidylinositol 3-kinase activation by CXCR4. J Exp Med 2010; 207: 247-261.
35. Huijskens MJAJ, Walczak M, Koller N, et al., Technical advance: Ascorbic acid induces development of double-positive T cells from human hematopoietic stem cells in the absence of stromal cells. J Leukoc Biol 2014; 96: 1165-1175.
36. Aoyama K, Delaney C, Varnum-Finney B, et al., The interaction of the Wnt and Notch pathways modulates natural killer versus T cell differentiation. Stem Cells 2007; 25: 2488-2497.
37. Delaney C, Heimfeld S, Brashem-Stein C, et al., Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010; 16: 232-236.
38. Fernandez I, Ooi TP, Roy K,. Generation of functional, antigen-specific CD8-+-human T cells from cord blood stem cells using exogenous notch and tetramer-TCR signaling. Stem Cells 2014; 32: 93-104.
39. Schmitt TM, de Pooter RF, Gronski MA, et al., Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nat Immunol 2004; 5: 410-417.
40. Lin J, Nie H, Tucker PW, et al., Controlled major histocompatibility complex-T cell receptor signaling allows efficient generation of functional, antigen-specific CD8-+-T cells from embryonic stem cells and thymic progenitors. Tissue Eng Part A 2010; 16: 2709-2720.
41. Galic Z, Kitchen SG, Kacena A, et al., T lineage differentiation from human embryonic stem cells. Proc Natl Acad Sci USA 2006; 103: 11742-11747.
42. Martin CH, Woll PS, Ni Z, et al., Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells. Blood 2008; 112: 2730-2737.
43. Timmermans F, Velghe I, Vanwalleghem L, et al., Generation of T cells from human embryonic stem cell-derived hematopoietic zones. J Immunol 2009; 182: 6879-6888.
44. Lei F, Haque R, Weiler L, et al., T lineage differentiation from induced pluripotent stem cells. Cell Immunol 2009; 260: 1-5.
45. Wada H, Kojo S, Kusama C, et al., Successful differentiation to T cells, but unsuccessful B-cell generation, from B-cell-derived induced pluripotent stem cells. Int Immunol 2010; 23: 65-74.
46. Kennedy M, Awong G, Sturgeon CM, et al., T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep 2012; 2: 1722-1735.
47. Brown ME, Rondon E, Rajesh D, et al., Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes. PLoS One 2010; 5: e11373-e11379.
48. Loh Y-H, Hartung O, Li H, et al., Reprogramming of T cells from human peripheral blood. Cell Stem Cell 2010; 7: 15-19.
49. Seki T, Yuasa S, Oda M, et al., Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010; 7: 11-14.
50. Chang C-W, Lai Y-S, Lamb LS, et al., Broad T-cell receptor repertoire in T-lymphocytes derived from human induced pluripotent stem cells. PLoS One 2014; 9: e97335.
51. Vizcardo R, Masuda K, Yamada D, et al., Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8-+-T cells. Cell Stem Cell 2013; 12: 31-36.
52. Nishimura T, Kaneko S, Kawana-Tachikawa A, et al., Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation. Cell Stem Cell 2013; 12: 114-126.
53. Guirguis LM, Yang JC, White DE, et al., Safety and efficacy of high-dose interleukin-2 therapy in patients with brain metastases. J Immunother 2002; 25: 82-87.
54. Lund TC, Boitano AE, Delaney CS, et al., Advances in umbilical cord blood manipulation-from niche to bedside. Nat Rev Clin Oncol 2015; 12: 163-174.
55. Sprent CDSJ,. Homeostasis of naive and memory T cells. Immunity 2008; 29: 848-862.
56. Papapetrou EP, Kovalovsky D, Beloeil L, et al., Harnessing endogenous miR-181a to segregate transgenic antigen receptor expression in developing versus post-thymic T cells in murine hematopoietic chimeras. J Clin Invest 2009; 119: 157-168.
57. Fedorov VD, Themeli M, Sadelain M,. PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses. Sci Transl Med 2013; 5: 215ra172-215ra172.
58. Chou B-K, Gu H, Gao Y, et al., A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: A clinically compliant approach. Stem Cells Transl Med 2015; 4: 320-332.
59. Salvagiotto G, Burton S, Daigh CA, et al., A defined, feeder-free, serum-free system to generate in vitro hematopoietic progenitors and differentiated blood cells from hESCs and hiPSCs. PLoS One 2011; 6: e17829.